Histone acetylases were originally identified because of their ability to acetylate histone substrates [1] [2] [3] . Acetylases can also target other proteins such as transcription factors [4] [5] [6] [7] . We asked whether the acetylase CREB-binding protein (CBP) could acetylate proteins not directly involved in transcription. A large panel of proteins, involved in a variety of cellular processes, were tested as substrates for recombinant CBP. This screen identified two proteins involved in nuclear import, Rch1 (human importin-α α) and importin-α α7, as targets for CBP. The acetylation site within Rch1 was mapped to a single residue, Lys22. By comparing the context of Lys22 with the sequences of other known substrates of CBP and the closely related acetylase p300, we identified G/SK (in the single-letter amino acid code) as a consensus acetylation motif. Mutagenesis of the glycine, as well as the lysine, severely impaired Rch1 acetylation, supporting the view that GK is part of a recognition motif for acetylation by CBP/p300. Using an antibody raised against an acetylated Rch1 peptide, we show that Rch1 was acetylated at Lys22 in vivo and that CBP or p300 could mediate this reaction. Lys22 lies within the binding site for a second nuclear import factor, importin-β β. Acetylation of Lys22 promoted interaction with importin-β β in vitro. Collectively, these results demonstrate that acetylation is not unique to proteins involved in transcription. Acetylation may regulate a variety of biological processes, including nuclear import. Table 1 shows that two nuclear import factors, Rch1 and importin-α7, were acetylated by recombinant CBP, as was the transcription factor HMG1. The fact that many proteins were not acetylated by CBP in this assay testifies to the specificity of the observed acetylation of import factors. The acetylation of HMG1 serves as a positive control, as it is already known to be acetylated in vivo at Lys2 and Lys11 [8] . A negative result in this screen does not, however, rule out the possibility that these substrates are acetylated by CBP or another acetylase in vivo.
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Rch1 is an importin-α isoform that recognises classical nuclear localisation signals (NLSs) and functions as an import adapter, allowing access to the importin-β-dependent import pathway. There are at least six importin-α isoforms in human [9, 10] . They all comprise two functional domains, an amino-terminal importin-β binding (IBB) domain that confers binding to and import by importin-β [11, 12] and an arm-repeat domain that harbours the NLS-binding site ( Figure 1a ). The acetylase domain of CBP acetylated Rch1 and importin-α7 at levels comparable to the acetylation of histones (Figure 1b) . Another family member, importin-α3 was, however, not acetylated by CBP, suggesting that acetylation may be relevant to the function of certain importin isoforms. Deletion analysis of Rch1 indicated that a domain composed of the amino-terminal 95 residues (1-95) was sufficient for acetylation by CBP, whereas a construct lacking this region (56-529) was not a substrate ( Figure 1c ).
The domain of Rch1 acetylated by CBP overlaps with the IBB domain [9] . The NLS-bound Rch1 has to interact with the nuclear pore-associated importin-β in order for nuclear import to take place [13, 14] . We therefore asked if the Rch1-importin-β association was affected by acetylation. We prepared in parallel two preparations of bacterially expressed Rch1: one acetylated by CBP using 14 C-acetyl-CoA and the other metabolically labelled with 35 S-methionine to serve as the control for binding. Approximately 0.5-1 µg of each recombinant protein was incubated with glutathione-S-transferase (GST)-CBP (residues 1098-1758) and 14 C-acetyl-CoA in a standard histone acetyltransferase reaction [17] . DS, double-stranded.
Equimolar amounts of each Rch1 preparation were then used in importin-β binding assays and the relative binding to importin-β was determined for each preparation (Figure 1d ). We found that the CBP-dependent acetylation of Rch1 increased its ability to bind importin-β by approximately 3-4-fold, suggesting that the acetylation of Rch1 seen here in vitro could regulate nuclear import.
To establish whether the acetylated lysine residue falls within the importin-β binding interface, we carried out a further deletion analysis. Figure 2a shows that this is the case. Crucially, residues 23-82 were not acetylated by CBP but when an additional six residues were included amino-terminally (17-82), acetylation was observed. This indicates that the motif FKNKGK can confer acetylation to Rch1. Protein sequence analysis of CBP-acetylated Rch1 confirmed that the acetylation site maps to this motif and involves only Lys22 (Figure 2b ). This mapping places the acetylated lysine at the interface between Rch1 and importin-β. Recently, the crystal structure of an Rch1 domain bound to importin-β has been reported [15] . The structure indicates that Lys22 is an unusual basic residue within the IBB domain because it does not form a stabilising salt bridge with any acidic residues from importin-β unlike the nearby residues Lys18 and Lys20. Thus, neutralisation of the basic charge of Lys22 by acetylation would not be predicted to be detrimental to the interaction. Perhaps the observed stabilisation of the interaction ( Figure 1d ) comes about because acetylation of Lys22 repositions its neighbours into a more favourable binding conformation.
Having established Lys22 as the site for acetylation in Rch1, we asked whether the context of this lysine is conserved One was metabolically labelled in Escherichia coli using 35 S-methionine, purified using Ni 2+ -agarose, eluted from the beads and then mock-acetylated, thereby serving as the control for binding. The other was prepared identically except that it was not labelled with 35 S-methionine but was radioactively acetylated by CBP using 14 C-acetyl-CoA. Z-tagged importin-β was also expressed in, and purified from, bacteria and was left attached to immunoglobulin G-agarose beads. A binding reaction (binding buffer: 50 mM Tris.Cl pH 7.5, 500 mM NaCl, 5 mM magnesium acetate, 10 mM β-mercaptoethanol) was then set up containing excess agarose-bound importin-β and an equimolar amount of either 35 S-labelled Rch1 or 14 C-acetylated Rch1. Reactants were slowly rotated at room temperature for 2 h. The reactions were then pelleted, washed extensively with binding buffer, resolved by SDS-PAGE and blotted. The relative binding to importin-β was determined for each preparation of Rch1 using a PhosphorImager. The results of two independent experiments are presented.
Figure 2
Lys22 of Rch1 is acetylated by CBP. (a) Rch1 residues 17-22 are crucial for acetylation by CBP. The indicated Rch1 deletions (see Figure 1a) were tested as substrates of CBP. Reactions were performed as described in Figure 1b and the resulting autoradiogram is shown.
(b) CBP acetylates Rch1 residue Lys22. A peptide fragment of Rch1 corresponding to amino acids 10-82 was 14 C-acetylated by CBP using standard conditions [18] . The reaction products were resolved by SDS-PAGE and blotted to PVDF membrane. Automated Edman degradation was performed on the blotted material and each cycle fraction was collected and counted using a liquid scintillation counter.
relative to CBP-acetylated lysines in other proteins. An alignment of other known CBP targets (Figure 3a) indicates that the only detectable preference is a glycine or serine residue directly preceding the acetylated lysine. The exception is p53, which has a lysine at this position and one of the sites in histone H4 that has an alanine.
To assess the importance of the conserved GK sequence in Rch1, we carried out a mutagenic analysis. Mutating Gly21 severely disrupted acetylation by CBP; the severity of this mutation was comparable to mutating the acetylated lysine, Lys22 (Figure 3b ). In contrast, mutating Lys18 and Lys20 had little or no effect. Essentially identical results were obtained using p300 (data not shown).
The importance of the GK sequence for CBP/p300 acetylation is consistent with the finding that importin-α3, which does not have a GK sequence, was not acetylated by CBP (Figure 1b) . Moreover, these results are consistent with the recently reported crystal structure of the Tetrahymena GCN5 acetylase bound to a histone H3 peptide, which indicates that a glycine residue immediately preceding the acetylated lysine within H3 is important for recognition by the acetylase [16] . These results indicate that residues other than lysines are necessary as a recognition site for a mammalian acetylase. We suspect that other determinants, less obvious than the glycine or serine residue, may also be necessary to determine the specificity, because some of the proteins that are not
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Figure 3
The GK motif is required for efficient acetylation of Rch1 by CBP. (a) Alignment of known CBP acetylation sites within different substrates. The GK motif (see text) is shown in red. The lysine residues shown in red are known to be acetylated in vivo (HMG1 [8] , histone H4 [19] , GATA-1 [5] , HMG(I)Y [7] and p53 [4] ) and/or by CBP in vitro (Rch1 (this study), histone H4 [20] , GATA-1 [5] , TFIIE [21] , HMG(I)Y [7] and p53 [4] (or the indicated mutant) was used as substrate for CBP essentially as described for Figure 1 , except that following SDS-PAGE the Rch1 band was excised and the amount of acetylation determined by liquid scintillation counting. The amount of acetylation is given relative to that of wild-type Rch1. These data are expressed graphically on the right.
Figure 4
Rch1 is acetylated by p300 at Lys22 in vivo. substrates for CBP in Table 1 do contain G/SK residues. Nevertheless, the G/SK sequence can serve as a guide for potential CBP/p300 acetylation sites once a protein is demonstrated to be a CBP/p300 target.
We next asked whether Rch1 was acetylated at the GK motif in vivo. In order to do this, we raised a rabbit polyclonal antibody (AcK22) that specifically recognises acetylated Rch1 (Figure 4) . To test the specificity of the AcK22 antibody we first transfected a carboxy-terminally Histagged version of Rch1 into cells and, following purification, we western blotted with AcK22. The antibody recognized Rch1 efficiently when a deacetylase inhibitor, TSA, was included ( Figure 4a, compare lanes 1 and 2) . Introduction of exogenous p300 into cells increased dramatically the recognition of acetylated Rch1 by AcK22 (lane 3). These results confirm that AcK22 recognises acetylated Rch1 in vivo. To confirm that the acetylation on Rch1 occurred at the GK motif, we used a peptide competition assay. Figure 4b shows that recognition of acetylated Rch1 by the AcK22 antibody was not inhibited by a peptide containing an unacetylated GK motif (Figure 4b , compare lanes 1 and 2). When the peptide was acetylated specifically at Lys22, however, it could effectively compete for the recognition of Rch1 by the AcK22 antibody. In contrast, an acetylated control peptide derived from the transcription factor E2F1 (which is known to be acetylated in vivo, [17] ) did not compete for the recognition of acetylated Rch1. These results therefore show that the AcK22 antibody recognises specifically the acetylated version of Rch1 and that this recognition is context-dependent, that is, it recognises acetylated Lys22 only in the context of Rch1. We can therefore conclude that Rch1 can be acetylated in vivo by p300 and that this acetylation takes place at Lys22.
Finally, we asked whether the AcK22 antibody could detect endogenous acetylated Rch1 in a total cellular extract in which Rch1 had not been overexpressed (Figure 4c ). AcK22 weakly recognized a band (lane 1, asterisk) that comigrated with Rch1 (lane 5). The other proteins recognized by the AcK22 antibody in lane 1 may correspond to importin-α isoforms. Significantly, the asterisked band in lane 1 has the characteristics of acetylated Rch1, as determined for transfected Rch1 in Figure 4a . Thus, detection of endogenously acetylated Rch1 was augmented slightly by the addition of TSA or by p300 transfection (lanes 2 and 3) and synergistically when both TSA and p300 were present (lane 4). These observations, plus the characterised specificity of AcK22 (Figure 4b ), confirm that endogenous Rch1 is acetylated. However, the acetylated form could be detected only when the balance was biased towards the acetylated state. This is presumably because Rch1 acetylation is tightly controlled in vivo.
Our results point to the possibility that nuclear import may be subject to regulation by acetylation. Acetylation of Rch1 by CBP/p300 is likely to take place in the nucleus where CBP/p300 are localised, but may also affect the function of Rch1 when it shuttles to the cytoplasm. How acetylation regulates nuclear import functions remains to be established, but the results presented here suggest that acetylation may not necessarily be confined to the regulation of transcription, but may well affect other cellular processes, such as nuclear import.
